Un equipo de investigadoras ha coordinado un estudio donde han revelado el mecanismo de acción del péptido G49 sobre la pérdida de peso en ratones obesos, identificando cambios metabólicos similar...
Read moreIt has been developed a new therapy based on nanotechnology called nanoGLA for the treatment of Fabry disease. The new therapeutic solution has shown remarkable efficacy in preclinical studies
Read morePediococcus acidilactici PA1C® improves the beneficial effects of metformin treatment in type 2 diabetes by controlling glycaemia and modulating intestinal microbiota
Read moreAn international scientific team, led by the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), has designed a chemical compound called MACTIDE-V, capable of reprogramming the activity of thes...
Read moreEl Instituto de Neurociencias de Castilla y León (INCYL) trabaja en una línea de investigación contra el glioblastoma y ha logrado resultados prometedores
Read moreIn the frame of World Cancer Day, held on 4th February, various research projects at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) stand out for their efforts to find new therapeutic s...
Read moreThe project, led by the Catalan company Linkcare, aims to launch an innovative solution that can improve early screening of the 270,000 new cases of this disease each year.
Read moreEste evento bianual es un punto de encuentro destacado para investigadores portugueses y españoles especializados en la ciencia de los péptidos, y representa una oportunidad única para fomentar col...
Read moreSemaglutide has emerged as a groundbreaking therapy for managing type 2 diabetes, marketed under brand names like Ozempic. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it significantly benef...
Read moreLa investigadora del Instituto de Neurociencias UMH-CSIC ha recibido 300.000 dólares de la Alzheimer’s Association para estudiar la relación entre la proteína apoE y el alzhéimer durante 3 años...
Read moreInvestigadores de la Universidad Politécnica de Madrid trabajan en el desarrollo de una nueva generación de implantes con moléculas bioactivas incorporadas que permitirá su integración óptima en...
Read more